# TRETINOIN
> **ANDA217804** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2024-04-29
## Drug
- **FDA Application Number:** ANDA217804
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRETINOIN
- **Generic name:** TRETINOIN
- **Active ingredients:** TRETINOIN
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2024-04-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217804)
---
*AI Analytics · CC0 1.0*